Hetrombopag Clinical Trials
5 recruitingDrug
Phase 23Not Applicable1Phase 41
Showing 1–5 of 5 trials
Recruiting
Phase 2
Efficacy and Safety of Hetrombopag in Preventing Chemotherapy-induced Thrombocytopenia in Gastrointestinal Tumors
Chemotherapy-induced Thrombocytopenia (CIT) in Patients With Gastrointestinal Tumors
Changhai Hospital40 enrolled1 locationNCT07492693
Recruiting
Not Applicable
Hetrombopag in Promoting Platelet Engraftment After Auto-HSCT in Children With Neuroblastoma
NeuroblastomaDelayed Platelet EngraftmentAutologous Hematopoietic Stem Cell Transplantation
Beijing Children's Hospital30 enrolled1 locationNCT06818916
Recruiting
Phase 2
A Clinical Study of Hetrombopag Olamine Tablets for Thrombocytopenia Induced by Anti-tumor Treatment in Advanced Breast Cancer
Breast Cancer
Henan Cancer Hospital60 enrolled2 locationsNCT05394285
Recruiting
Phase 4
Clinical Study on Efficacy and Safety of Hetrombopag in the Preoperative Patients of Thrombocytopenia
Thrombocytopenia
The Third People's Hospital of Chengdu55 enrolled1 locationNCT06562738
Recruiting
Phase 2
Efficacy and Safety of Herombopag in Patients With Thrombocytopenia Before Hepatectomy
Hepatopathy
Fudan University96 enrolled1 locationNCT05442632